Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
2012
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
2009
Are oral cannabinoids safe and effective in refractory neuropathic pain?
2003
Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging
2018
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters
2011
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review
2015
Current trials in multiple sclerosis: established evidence and future hopes
2005
Exercise interventions to improve sleep in cancer patients: A systematic review and meta-analysis
2016
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
2003
The safety of cannabinoids for the treatment of multiple sclerosis
2005
Adverse Health Effects of Marijuana Use
2014 Standout
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
2006
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
2006
Complementary and alternative medicine: use and disclosure in radiation oncology community practice
2010 Standout
Descending control of pain
2002 Standout
Emerging properties of cannabinoid medicines in management of multiple sclerosis
2005
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
2005
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
2007
Dietary Supplement Use in Cancer Care: Help or Harm
2008
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Natural products: An evolving role in future drug discovery
2011 Standout
The therapeutic potential of cannabis in multiple sclerosis
2003
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
2004
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Seasonal changes in plasma glucocorticoid concentrations in free-living vertebrates
2002 Standout
Cannabinoid-based drugs as anti-inflammatory therapeutics
2005
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
2005
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
2009
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
2013
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Sex Pheromones and Their Impact on Pest Management
2010 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212
2003
Understanding the mechanisms and treatment options in cancer cachexia
2012
Cancer-associated cachexia
2018 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cannabinoids and Multiple Sclerosis
2007
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
2006
Pharmacokinetics and Pharmacodynamics of Cannabinoids
2003
Cannabinoids and neuroprotection in CNS inflammatory disease
2005
Daily and Seasonal Variation in Response to Stress in Captive Starlings (Sturnus vulgaris): Corticosterone
2000
Appraisal of current and experimental approaches to the treatment of cachexia
2007
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
2008
Sarcopenia
2019 Standout
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
2007
Cannabinoids in Multiple Sclerosis
2004
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
2005
Phytochemistry of Cannabis sativa L.
2017 Standout
G protein-coupled receptors as therapeutic targets for multiple sclerosis
2012
Chapter 3 Neurogenetics of Courtship and Mating in Drosophila
2008 StandoutNobel
Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q
2009 Standout
Cannabinoids in medicine: A review of their therapeutic potential
2006
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
2009
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
2012
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations
2007
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
2010
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception
2004
Cannabinoids and multiple sclerosis
2002
Weight loss in patients with advanced cancer: effects, causes, and potential management
2008
Human Cannabinoid Pharmacokinetics
2007 Standout
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
2004
Human Studies of Cannabinoids and Medicinal Cannabis
2005
Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
2008 Standout
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
A systematic review of health-related quality of life instruments in patients with cancer cachexia
2013
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
2007
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212
2003
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?
2003
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
2006
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
2003
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances
2007
Cannabinoids in health and disease
2007
The effect of cannabis on tremor in patients with multiple sclerosis
2004
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
2010
Prognostic Factors in Patients With Advanced Cancer: Use of the Patient-Generated Subjective Global Assessment in Survival Prediction
2010
The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
2013
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Cannabinoids for Medical Use
2015 Standout
Wired for Sex: The Neurobiology of Drosophila Mating Decisions
2008 Science
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
2005
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
The voyeurs’ guide to Drosophila melanogaster courtship
2003
Anti-spasticity agents for multiple sclerosis
2003
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
2004
Physiology of Microglia
2011 Standout
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist
2004
Works of Marcus Reif being referenced
Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
1999
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
2013
Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabisprodukten im deutschen Sprachraum
1999
Evolutionary significance of courtship conditioning in Drosophila melanogaster
2002
Lack of Analgesia by Oral Standardized Cannabis Extract on Acute Inflammatory Pain and Hyperalgesia in Volunteers
2008
Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
2006
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
2004
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
2002
Multimodal Therapy Concept and Aerobic Training in Breast Cancer Patients With Chronic Cancer-Related Fatigue
2012